Cleopatra Hospitals Group S.A.E. (EGX:CLHO)

EGX:CLHO Income Statement

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	6,430	5,420	3,595	2,584	2,549	1,990
Revenue Growth (YoY)	46.70%	50.76%	39.13%	1.36%	28.13%	10.64%
Cost of Revenue	3,971	3,407	2,387	1,719	1,619	1,300
Gross Profit	2,459	2,013	1,209	865.27	930.67	689.57
Selling, General & Admin	894.86	749.8	494.19	376.47	344.94	256.45
Other Operating Expenses	52.86	50.93	10.46	14.51	11.96	18.44
Operating Expenses	1,023	851.56	551.86	419.36	402.87	327.36
Operating Income	1,436	1,162	656.76	445.91	527.79	362.22
Interest Expense	-177.92	-122.05	-69.55	-35.72	-34.44	-2.16
Interest & Investment Income	40.07	35.15	25.02	37.08	59.59	49.14
Currency Exchange Gain (Loss)	7.78	7.78	2.78	8.42	-0.01	-0.28
Other Non Operating Income (Expenses)	-0.01	-0.01	-3.29	-	-	-
EBT Excluding Unusual Items	1,306	1,083	611.71	455.68	552.93	408.91
Merger & Restructuring Charges	-1.23	-0.9	-2.3	-4.29	-17.52	-13.16
Gain (Loss) on Sale of Assets	1.91	1.91	-0.32	0.21	-0.79	0.48
Pretax Income	1,307	1,084	609.09	451.6	534.62	396.22
Income Tax Expense	334.8	266.65	135.53	93.37	123.95	98.58
Earnings From Continuing Operations	971.79	817.01	473.56	358.23	410.67	297.65
Earnings From Discontinued Operations	-	-	-4.26	-1.5	-	-
Net Income to Company	971.79	817.01	469.3	356.73	410.67	297.65
Minority Interest in Earnings	-122.65	-93.67	-51.12	-30.97	-23.43	-10.72
Net Income	849.14	723.35	418.18	325.76	387.25	286.92
Preferred Dividends & Other Adjustments	156.06	156.06	98.6	67.95	66.13	47.21
Net Income to Common	693.08	567.29	319.58	257.81	321.12	239.71
Net Income Growth	53.79%	72.97%	28.37%	-15.88%	34.97%	11.47%
Shares Outstanding (Basic)	1,442	1,442	1,442	1,515	1,599	1,600
Shares Outstanding (Diluted)	1,444	1,444	1,444	1,517	1,599	1,600
Shares Change (YoY)	-0.08%	-	-4.82%	-5.11%	-0.08%	-
EPS (Basic)	0.48	0.39	0.22	0.17	0.20	0.15
EPS (Diluted)	0.47	0.39	0.22	0.17	0.20	0.15
EPS Growth	49.50%	77.27%	30.17%	-15.50%	33.50%	13.20%
Free Cash Flow	-855.84	-1,204	-267.2	15.19	365.99	-230.21
Free Cash Flow Per Share	-0.59	-0.83	-0.18	0.01	0.23	-0.14
Gross Margin	38.24%	37.14%	33.62%	33.48%	36.51%	34.66%
Operating Margin	22.33%	21.43%	18.27%	17.26%	20.70%	18.21%
Profit Margin	10.78%	10.47%	8.89%	9.98%	12.60%	12.05%
Free Cash Flow Margin	-13.31%	-22.21%	-7.43%	0.59%	14.36%	-11.57%
EBITDA	1,642	1,346	811.22	581.11	643.75	448.59
EBITDA Margin	25.53%	24.83%	22.56%	22.49%	25.25%	22.55%
D&A For EBITDA	205.78	184.26	154.46	135.19	115.95	86.37
EBIT	1,436	1,162	656.76	445.91	527.79	362.22
EBIT Margin	22.33%	21.43%	18.27%	17.26%	20.70%	18.21%
Effective Tax Rate	25.62%	24.61%	22.25%	20.67%	23.18%	24.88%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.